Peer-influenced content. Sources you trust. No registration required. This is HCN.

Articles related to DEVICE/DRUG APPROVALS

Oncology News Central (ONC)

FDA Updates Temozolomide Indications and Dosing

Oncology, Medical September 19th 2023

Practical Neurology

First Biosimilar to Treat Relapsing Multiple Sclerosis Approved by FDA

Neurology September 6th 2023

Psychiatrist.com

Emerging Therapies for Attention-Deficit/Hyperactivity Disorder

Internal Medicine September 6th 2023

Myeloma Research News

Elranatamab, Now Elrexfio, Approved for Hard-to-treat Myeloma

Hematology/Oncology September 5th 2023

Practical Neurology

FDA Grants Orphan Drug Designation to Exon 44 Skipping AOC for Duchenne Muscular Dystrophy

Neurology August 30th 2023

Oncology News Central (ONC)

New Frontline Standard for Urothelial Carcinoma Comes With Questions

Oncology, Medical August 28th 2023

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form